Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 6, 1998, Pages 616-622

  Saiki, T ^b   Mitsuyama, K ^a   Toyonaga, A ^b   Ishida, H ^b   Tanikawa, K ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Cytokine; Inflammatory bowel disease; Stool

Indexed keywords

CYTOKINE; ELASTASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; MALE;

EID: 0031837897     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171891     Document Type: Article

References (38)

1. Podolsky DK. Inflammatory bowel disease. I. N Engl J Med 1991;325:928-37.
2. Fiocchi C. Cytokines. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams & Wilkins; 1994. p. 106-22.
3. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106: 533-9.
4. Reinecker H-C, Schreiber S, Stenson WF, MacDermott RP. The role of the mucosal immune system in ulcerative colitis and Crohn's disease. In: Ogra PL, Strober W, Mestecky J, McGhee JR, Lamm ME, Bienenstock J, editors. Handbook of mucosal immunology: San Diego (CA): Academic Press; 1994. p. 439-56.
5. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, et al. Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
6. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
7. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
8. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-35.
9. Van Dullemen HM, Van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, et al. Treatment of Crohn's disease with anti-tumor-necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
10. Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995;108:1434-44.
11. Braegger CP, Nicholls S, Murch SH, Stephens S, Mac Donald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992;339:89-91.
12. Nicholls S, Stephens S, Braegger CP, Walker-Smith JA, Macdonald TT. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J Clin Pathol 1993; 46:757-60.
13. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-8.
14. Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961;120:393-407.
15. Myren J, Bouchier IAD, Watkinson G, Softles A, Clamp SE, de Dombal FT. The O.M.G.E. multinational inflammatory bowel disease survey 1976-1982. A further report on 2,657 cases. Scand J Gastroenterol 1984;19 Suppl 95:1-27.
16. Raqib R, Wretlind B, Andersson J, Lindberg AA. Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis 1995;171: 376-84.
17. Raqib R, Lindberg AA, Björk L, Bardhan PK, Wretlind B, Andersson U, et al. Down-regulation of gamma interferon, tumor necrosis factor type 1, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor β type I receptors at the local site during the acute phase of shigella infection. Infect Immunol 1995;63:3079-87.
18. Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 1997;112:152-6.
19. Howard M, O'Garra A, Ishida H, de-Waal-Malefyt R, de-Vries J. Biological properties of interleukin 10. J Clin Immunol 1992;12:239-47.
20. Adeyemi EO, Hodgson HJF. Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 1992; 27:139-42.
21. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989; 30:835-8.
22. Mitsuyama K, Sasaki E, Toyonaga A, Ikeda H, Tsuruta O, Irie A, et al. Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion 1991;50:104-11.
23. Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994;96:432-6.
24. Nishiyama T, Mitsuyama K, Toyonaga A, Sasaki E, Tanikawa K. Colonic mucosal interleukin I receptor antagonist in inflammatory bowel diseae. Digestion 1994;55:368-73.
25. Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immunol 1995;154: 2434-40.
26. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301-5.
27. Nielsen OH, Køppen T, Rudiger N, Horn T, Eriksen J, Kirman I. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 1996;41:1786-93.
28. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ. whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-70.
29. Radford-Smith G, Jewell DP. Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol 1996;10:151-64.
30. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12:404-10.
31. Beutler B, Cerami A. The biology of cachectin/TNF - a primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
32. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin-4: Suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 1989;86:3803-7.
33. Vannier E, Miller LC, Dinarello CA. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992;89:4076-80.
34. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
35. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200.
36. Zimmerman MJ, Jewell DP. Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease. Aliment Pharmacol Ther 1996;10:93-8.
37. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-41.
38. Eckmann L, Jung HC, Schürer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993;105:1689-97.